EUVIMEDEUVIMED entdecken
Open Access

Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters

Tamarand L Darling iD, Houda H Harastani iD, Astha Joshi iD, Traci L Bricker, Nadia Soudani iD, Kuljeet Seehra iD, Ahmed O Hassan, Michael S Diamond iD, Adrianus C M Boon iD

Science Advances · 02.08.2024 · 10 (31)

DOI: 10.1126/sciadv.adp1290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 02.08.2024. Verfasst von Tamarand L Darling und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Vaccines, Mesocricetus. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

COVID-19 vaccines have successfully reduced severe disease and death after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Nonetheless, COVID-19 vaccines are variably effective in preventing transmission and symptomatic SARS-CoV-2 infection. Here, we evaluated the impact of mucosal or intramuscular vaccine immunization on airborne infection and transmission of SARS-CoV-2 in Syrian hamsters. Immunization of the primary contact hamsters with a mucosal chimpanzee adenoviral-vectored vaccine (ChAd-CoV-2-S), but not intramuscular messenger RNA (mRNA) vaccine, reduced infectious virus titers ~100-fold and 100,000-fold in the upper and lower respiratory tract of the primary contact hamster following SARS-CoV-2 exposure. This reduction in virus titer in the mucosal immunized contact animals was sufficient to eliminate subsequent transmission to vaccinated and unvaccinated hamsters. In contrast, sequential transmission occurred after systemic immunization with the mRNA vaccine. Thus, immunization with a mucosal COVID-19 vaccine protects against cycles of respiratory transmission of SARS-CoV-2 and can potentially limit the community spread of the virus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 VaccinesMesocricetusAnimalsCricetinaeImmunizationVaccinationHumansSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, Viral

Substanzen

COVID-19 VaccinesSpike Glycoprotein, CoronavirusAntibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
  • Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.

ORCID-Profile: Tamarand L Darling, Houda H Harastani, Astha Joshi, Nadia Soudani, Kuljeet Seehra, Michael S Diamond, Adrianus C M Boon

Förderung

  • NIAID NIH HHS

Zitieren

APA

Darling, T. L., Harastani, H. H., Joshi, A., Bricker, T. L., Soudani, N., Seehra, K., Hassan, A. O., Diamond, M. S., & Boon, A. C. M. (2024). Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters. Science Advances, 10(31). https://doi.org/10.1126/sciadv.adp1290

Vancouver

Darling TL, Harastani HH, Joshi A, Bricker TL, Soudani N, Seehra K, et al. Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters. Science Advances. 2024;10(31). doi:10.1126/sciadv.adp1290

BibTeX
@article{Darling2024,
  author = {Darling, Tamarand L and Harastani, Houda H and Joshi, Astha and Bricker, Traci L and Soudani, Nadia and Seehra, Kuljeet and Hassan, Ahmed O and Diamond, Michael S and Boon, Adrianus C M},
  title = {Mucosal immunization with ChAd-SARS-CoV-2-S prevents sequential transmission of SARS-CoV-2 to unvaccinated hamsters},
  journal = {Science Advances},
  year = {2024},
  volume = {10},
  number = {31},
  doi = {10.1126/sciadv.adp1290}
}
Kostenlos starten →